Clinical Trials in Seattle

Showing 5101-5120 of 9,312 trials

An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

NCT01129024

The primary objective of this study was to assess the long-term safety of lusutrombopag in the treatment of adults with relapsed persistent or chronic ITP with or without prior splenectomy.

Immune Thrombocytopenia

Shionogi19 participantsStarted Apr 2010

Anaheim, California, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +16 more locations

COMPLETEDPhase 1< 1 mile

Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer

NCT01322802

This phase I trial is studying the side effects of vaccine therapy in treating patients with stage III-IV or recurrent ovarian cancer. Vaccines made from deoxyribonucleic acid (DNA) may help the body build an effective immune response to kill tumor cells.

Stage III Ovarian Epithelial CancerStage III Ovarian Germ Cell TumorStage IV Ovarian Epithelial Cancer+1 more

University of Washington25 participantsStarted Mar 2012

Seattle, Washington, United States

An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer

Find Trials by Condition in Seattle

TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer

Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)

Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination

Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis

A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma

PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders

MEK162 for Patients With RAS/RAF/MEK Activated Tumors

Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration

Celebrex In Acute Gouty Arthritis Study

Epiduo Pediatric Acne Study

Phase 3 Papulopustular Rosacea Study

MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma

Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients